iTeos Therapeutics, Inc. (ITOS): insider trading, Congress trades & who owns it

Insider signal
54/100
Neutral · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$0
0 sellers · 12 months
Funds holding
—
13F filings
Congress trades
None
none in 2 years

There have been no open-market insider trades at iTeos Therapeutics, Inc. in the last 12 months.

Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.

Want the full picture on ITOS? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full ITOS report — free account

Latest insider trades in ITOS

FiledInsiderRoleTypeSharesPriceValueSource
Jun 11, 2025Detheux MichelCEOSell8,400$10.03$84KSEC
Jun 11, 2025Detheux MichelCEOSell8,400$10.02$84KSEC
Jun 11, 2025Detheux MichelCEOSell43,883$10.02$440KSEC
Jun 11, 2025Detheux MichelCEOSell43,882$10.03$440KSEC
Jun 6, 2025Detheux MichelCEOSell8,400$10.10$85KSEC
Jun 6, 2025Detheux MichelCEOSell43,883$10.10$443KSEC
Jun 6, 2025Detheux MichelCEOSell8,400$10.15$85KSEC
Jun 6, 2025Detheux MichelCEOSell43,882$10.15$445KSEC
Jun 6, 2025Detheux MichelCEOSell43,882$10.21$448KSEC
Jun 6, 2025Detheux MichelCEOSell8,400$10.21$86KSEC
Jun 6, 2025Hallal DavidDirectorSell38,227$10.07$385KSEC
Jun 6, 2025Hallal DavidDirectorSell38,227$10.15$388KSEC
Jun 6, 2025Hallal DavidDirectorSell38,228$10.24$391KSEC
May 16, 2025EcoR1 Capital, LLC10% OwnerBuy3,300,000$8.00$26.4MSEC
May 16, 2025EcoR1 Capital, LLC10% OwnerBuy1,658,978$7.41$12.3MSEC

Questions about ITOS

Are insiders buying or selling ITOS stock?

There were no open-market insider trades in ITOS in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

Has any member of Congress traded ITOS?

No congressional trades in ITOS were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).